Introduction
============

The Japanese Society for Vascular Surgery (JSVS) has independently collated all vascular surgical procedures in Japan since 2004. Furthermore, since 2011, almost all surgical cases in Japan have been registered in the National Clinical Database (NCD), which was launched that year, when the registration of surgical cases commenced. The JSVS has used these data to publish an annual report on vascular surgery. The present report summarizes the vascular surgical procedures registered in NCD, with an analysis of these procedures by the database management committee members of the JSVS.

It must be noted that data collection methods greatly differed from those of "Vascular Surgery Case Totals" published on the JSVS website, which was conducted in 2004--2010. Until 2010, JSVS conducted an annual questionnaire survey of institutions that performed vascular surgery and published an analysis of the data. Each reporting institution reviewed and summarized its surgical procedures for the year and reported the summary to JSVS. In 2010, 53,821 vascular surgical cases were reported by 311 institutions. The questionnaire response rate was extremely high at 98.7%; thus, this process provided an important contribution to establishing the situation nationwide. In contrast, the 2011 annual report, which is introduced in the present report, collated data that had been prospectively registered for each individual case by each institution at the time of surgery. A disadvantage of this system is that incorrect or missing data, if not removed from the analysis, could result in inconsistencies between the total number of procedures and the summarized results. Conversely, the prospective nature of the registry is a great advantage. Furthermore, 992 institutions registered vascular surgical procedures, representing an increase to approximately three times the number of institutions that had previously completed the questionnaires; thus, a major characteristic of the new system is the extensive, comprehensive nature of the data collection. However, the different data collection methods indicate that caution is required when comparing the results of the annual reports since 2011 with those of the questionnaire surveys prior to 2010.

Caution should also be exercised regarding possible overlaps with databases for other fields, particularly those of departments of cardiovascular surgery. Most cases of surgical procedures for the major vessels, especially thoracic aorta surgery, are input into the Japan Adult Cardiovascular Surgery Database (JACVSD); for this reason, the overall vascular surgery data presented in this report do not include information about thoracic aorta surgery. Possible overlaps with departments that administer medical care other than surgery should also be considered. Many patients receive endovascular treatment for peripheral blood vessels from departments of cardiovascular medicine or radiology, but this database does not include data on the number of endovascular procedures performed at these departments. Similarly, venous and lymphatic surgical procedures performed by departments of plastic surgery and limb amputations performed by departments of orthopedics are not included.

Methods
=======

At the request of JSVS, a governing society of NCD, vascular surgery data for 2011 were extracted. The categories were tabulated and then checked by members of the database management committee of JSVS, and the tabulation results were analyzed, resulting in the following seven categories: 1) treatment for aneurysm, 2) revascularization for chronic arterial occlusion, 3) revascularization for acute arterial occlusion, 4) treatment for vascular trauma, 5) treatment for vascular complications after revascularization, 6) venous surgery, and 7) other vascular disease and related surgery.

The summarized results present the number of cases according to the different surgical procedures, with the underlying pathology, number of operative mortality, inhospital mortality, and the materials used. Operative mortality, which is synonymous with surgery-related death, is defined as all deaths within 30 days of surgery, irrespective of the cause or whether the patient died at the hospital. Inhospital mortality refers to patients who died at any time after the surgery during the same hospital stay.

There are discrepancies in the values given in the table; for example, the totals for the underlying pathology and materials used are inconsistent with the total number of cases. However, careful investigation by this committee and the data analysis team of NCD concluded that the discrepancies resulted from one of the following four factors: 1) input options that permitted multiple responses, 2) input options that permitted null entries, 3) omissions or incorrect input by the individual entering the data, or 4) the use of several materials or treatment of several sites during a single procedure. Since 2013, every effort has been made to implement countermeasures to avoid erroneous input and omissions as far as possible, such as programs for the provision and establishment of options and items that prevent registration of records that include null data.

Results
=======

In 2011, a total of 1,172,574 surgical procedures performed at 3,008 institutions were registered in NCD, including 71,707 (6.1%) vascular surgical procedures performed at 992 (33.0%) institutions. Of these 992 institutions, 337 (34%) were authorized training institutions for cardiovascular surgery that contributed to this data registration as of 2011. A total of 39,458 cardiovascular surgical procedures were performed at authorized institutions; a high proportion of these were procedures for aneurysms and vascular trauma, with venous surgery, surgery for other vascular diseases, and related procedures accounting for less than half of the procedures ([**Fig. 1**](#figure1){ref-type="fig"}). The 2011 results and analyses by category are outlined below. Statistical analyses were performed using the chi-square test, with p-values of \<0.05 considered to indicate statistical significance.

![Fig. 1 The number of annual operations in each category. The percentage values and the shadow parts demonstrate the proportion of operations performed in the institutions certified by Japanese Board of Cardiovascular Surgery.](avd-11-3-ar.18-00049-figure01){#figure1}

1. Treatment of Aneurysms (**Table 1**)
=======================================

1) Aneurysms of the thoracic aorta
----------------------------------

###### Table 1 Treatment for aneurysm Table 1-1 Aortic aneurysm

  Region of aortic aneurysm          Cases    Gender   Mortality   Ruptured aneurysm   Dissection\*^3)^   Etiology   Treatment procedures   Graft materials\*^7)^                                                                                                                     
  ---------------------------------- -------- -------- ----------- ------------------- ------------------ ---------- ---------------------- ----------------------- ----- -------- ----- ----- ----- ---- ----- ---- ----- -------- ------- ------- ----- ------- ----- ------- ----- ----
  Ascending aorta\*^1)^              778      383      395         103                 128                103        22                     25                      570   642      87    106   0     2    3     20   107   778                      2     13      7     690     50    8
  Aortic arch\*^1)^                  908      663      245         93                  114                89         19                     20                      306   791      83    97    0     1    9     26   79    908                      7     256     140   538     114   17
  Descending thoracic aorta\*^1)^    661      499      162         48                  61                 81         16                     22                      239   552      38    48    4     2    11    22   69    661                      6     418     37    208     32    5
  Thoracoabdominal aorta\*^1)^       401      301      100         29                  45                 58         17                     21                      88    348      22    36    6     0    10    8    25    401                      16    176     34    156     65    7
  Abdominal aortic aneurysm\*^2)^    13,218   10,917   2,301       332                 454                1,253      236                    280                     360   12,466   302   410   211   12   184   36   277   13,218   6,004   1,076   143   5,873   74    6,716   336   87
  with renal artery reconstruction   244      190      54          12                  14                 12         3                      3                       15    226      12    13    3     2    4     1    6     244      193     39      4     0       7     228     16    6
  with renal artery clamping         978      807      171         58                  74                 137        36                     40                      41    899      55    65    26    2    28    2    17    978      767     199     13    0       8     940     33    10

###### Table 1-2 Abdominal aortic aneurysm mortality classified by treatment procedures

  Procedure for aneurysm repair   Ruptured aneurysm   Non-ruptured aneurysm                      
  ------------------------------- ------------------- ----------------------- ----- ------- ---- -----
  Replacement                     1,025               197                     233   6,041   65   119
  Exclusion with bypass           43                  9                       13    100     3    5
  Stent graft                     174                 23                      27    5,693   27   48
  Hybrid                          3                   2                       2     71      1    2

###### Table 1-3 Peripheral artery aneurysm

  Aneurysm                    Cases   Gender   Mortality   Ruptured aneurysm   Etiology   Treatment procedures   Graft materials for open surgery                                                                                     
  --------------------------- ------- -------- ----------- ------------------- ---------- ---------------------- ---------------------------------- ---- ----- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ---
  Aortic arch branches                                                                                                                                                                                                                
  Carotid                     8       6        2           0                   0          1                      0                                  0    3     0    1     2     2     0     1     3     1     2     0     0     1     0
  Verterbral                  0       0        0           0                   0          0                      0                                  0    0     0    0     0     0     0     0     0     0     0     0     0     0     0
  Subclavian                  31      25       6           3                   4          4                      2                                  2    18    1    6     3     3     5     5     6     11    4     2     4     3     0
  Multiple in arch branches   0       0        0           0                   0          0                      0                                  0    0     0    0     0     0     0     0     0     0     0     0     0     0     0
  Others                      19      12       7           2                   3          10                     1                                  2    9     0    4     0     6     2     3     6     3     5     3     0     1     0
  Upper limb artery                                                                                                                                                                                                                   
  Axillar                     13      12       1           0                   1          1                      0                                  0    9     0    1     0     3     10    3     0     0     0     3     6     5     0
  Brachial                    184     94       90          2                   5          36                     1                                  2    29    1    31    48    74    40    7     82    0     54    6     16    23    1
  Forearm-hand                110     63       47          1                   1          13                     1                                  1    45    2    15    17    31    15    2     70    0     22    4     9     3     0
  Others                      64      39       25          2                   2          8                      0                                  0    14    0    9     4     37    11    3     40    0     9     2     9     3     0
  Visceral artery                                                                                                                                                                                                                     
  Celiac                      22      18       4           0                   0          2                      0                                  0    22    0    0     0     0     6     1     4     7     4     4     0     3     0
  Hepatic                     16      11       5           2                   2          3                      1                                  1    14    1    1     0     0     4     3     2     0     7     1     0     3     0
  Splenic                     46      22       24          0                   0          6                      0                                  0    39    1    0     0     6     1     1     10    1     33    0     0     1     0
  Superior mesenteric         18      17       1           1                   1          1                      0                                  0    10    1    4     0     3     4     2     7     1     4     0     1     5     0
  Renal                       42      26       16          1                   1          2                      1                                  1    38    0    0     0     4     4     7     7     3     21    0     0     7     0
  Others                      358     306      52          8                   8          42                     7                                  7    320   2    8     5     23    97    7     66    94    92    87    10    3     0
  Lower limb artery                                                                                                                                                                                                                   
  Femoral                     396     291      105         10                  20         86                     6                                  10   153   4    76    53    107   145   19    127   6     97    76    65    24    0
  Popliteal                   135     97       38          1                   1          16                     0                                  0    113   2    2     5     12    75    45    10    2     2     17    32    74    0
  Others                      121     85       36          0                   3          23                     0                                  2    78    0    10    6     27    31    8     29    17    35    15    8     14    1
  Total                       1,558   1,102    456         31                  50         249                    19                                 27   897   15   163   142   336   437   113   467   142   389   212   156   165   2

\*1) These data are not including cases recorded in JACVSD Database in which most cardiac surgeons were entering their cases. \*2) Including common iliac artery aneurysm. \*3) Including both acute and chronic aortic dissection. \*4) Most likely atherosclerotic. \*5) Connective tissue abnormalities such as Marfan syndrome. \*6) Debranch bypass surgery combined with two staged TEVAR is counted as one case of hybrid treatment. \*7) Only for open surgery. \*8) Including TAO, Takayasu aortitis, collagen disease related vasculitis, Behçet disease, fibromuscular dysplasia. Abbreviations; Y-graft: Y-shape artificial graft, T-graft: straight shape artificial graft, Polyester: polyester artificial graft such as Dacron graft, ePTFE: expanded polytetrafluoroethylene graft

Most procedures for aneurysms of the thoracic aorta were registered in JACVSD through the Japan Cardiovascular Surgery Database Organization, whereas some procedures performed by vascular surgeons were included in this vascular surgery database via NCD ([**Table 1**](#table1-1){ref-type="table"}[](#table1-2){ref-type="table"}[](#table1-3){ref-type="table"}). Thus, the registration of surgery for the thoracic aortic aneurysms in Japan is currently divided, making it impossible to obtain an accurate overall image of the current state. In addition to JACVSD, the Japan Association for Thoracic Surgery (JATS) conducts a questionnaire survey and presents an annual report in their journal.^[@R1])^ The data from this serve as a reference; however, the difference in collection method (by questionnaire rather than the reporting system used for the present report) and the lack of clarity on how many vascular surgeons who performed surgery for aneurysms of the thoracic aorta responded to the JATS questionnaire prevent the determination of the overall number of surgical procedures for aneurysms of the thoracic aorta conducted across Japan. Going forward, efforts must be made in cooperation with JACVSD to grasp an overview of surgery for aneurysms of the thoracic aorta throughout Japan.

2) Aneurysms of the abdominal aorta (**Tables 1-1** and **1-2**)
----------------------------------------------------------------

According to NCD, in 2011, there were 13,218 surgical cases for abdominal aortic aneurysms (AAA) (including iliac aneurysms), of which 82.6% involved men. In surveys of the number of surgical procedures conducted by JSVS before 2010, there were 8,610 surgeries overall for AAA, and it is thought that this discrepancy was considerably influenced by the difference in the method of collating the questionnaire surveys up to 2010 and by the increase in stent graft placement over the year. In 2011, the number of stent grafts registered in NCD was consistent with the number of annual stent grafts announced by the Japanese Committee for Stentgraft Management. In 2005, the total number of surgeries conducted for AAA in the USA was 41,185, which, given the population of approximately 300 million, is an incidence of 0.014%. The surgical incidence in Japan is approximately 0.011% per population calculated based on the total number of surgeries for the year, which is comparable to that of the USA. In the 2014 mortality rates ranked according to the leading causes of death announced by the Ministry of Health, Labour and Welfare of Japan, aortic aneurysm and aortic dissection were ranked as the 9th leading cause of death. Therefore, the treatment of aneurysm could affect the national death statistics.^[@R2])^

The pathology of AAA was caused by so-called arteriosclerotic degenerative disease in 94.3%, followed by so-called inflammatory aneurysm in 1.6%, and infected aneurysm in 1.4%, with low rates of primary connective tissue disease such as Marfan syndrome and vasculitis at 0.27% and 0.09%, respectively.

The surgical procedure involves a replacement using a Y-graft or tube graft in 53.6%, endovascular aneurysm repair (EVAR) using stent graft in 44.5%, and exclusion bypass in 1.1%. In the USA, stent grafting was approved by the Food and Drug Administration in 1999. In 2004, the numbers of EVAR and conventional surgeries were comparable, whereas in 2005, EVAR outnumbered conventional surgeries.^[@R3])^ Thus, in Japan, when stent grafting became applicable for coverage by national health insurance in November 2006, it was assumed that within a few years the number of EVAR would exceed that of replacement surgery. Most artificial vascular grafts used for replacement and exclusion bypass are made of polyester (94.4%), while polytetrafluoroethylene (PTFE) accounts for 4.7% of cases.

Among 7,345 patients with AAA, excluding EVAR, 978 patients required renal artery clamping due to pararenal AAA, 244 patients required renal artery reconstruction (3.3% of open repair cases, 1.8% of AAA overall). Of these, rupture was observed in 12 patients who underwent renal artery reconstruction and 137 patients who underwent renal artery clamping. The mortality rate was 25% for inpatients with rupture and renal artery reconstruction and 29.2% for inpatients with rupture and renal artery clamping. Excluding rupture patients, the mortality rate was 4.7% for inpatients with renal artery reconstruction in elective surgery and 4.0% for those with renal artery clamping, indicating considerably inferior results compared with elective surgery with clamping below the renal artery branch. Furthermore, in [**Table 1-1**](#table1-1){ref-type="table"}, the items "with renal artery reconstruction," "with renal artery clamping" and "graft materials" present numerical data for patients who underwent open repair, whereas patients who underwent stent grafting are not included.

There were 1,253 surgeries for rupture, for which the operative mortality rate was 18.8% and the inhospital mortality rate was 22.3%. Meanwhile, excluding rupture cases, operative death in elective surgery occurred in 96 out of 11,965 patients (0.8%), with inhospital death occurring in 174 out of 11,965 patients (1.5%). Although the year differs, in the USA in 2005, the mortality rate for rupture surgery was 40.5%, twice that of Japan. The mortality rate for elective surgery was 2.7%, indicating a better rate in Japan.^[@R3])^ Among long-term dialysis patients, the operative mortality rate was 3.0% and the inhospital mortality rate was 4.8%. Although the proportion accounting for rupture cases is unclear, the mortality rate is inferior to that of non-dialysis patients.

A differential analysis of the early outcomes of surgical replacement and stent grafting was performed according to the presence or absence of rupture ([**Table 1-2**](#table1-2){ref-type="table"}). For replacement surgery in patients without rupture, operative mortality was 1.1%, and inhospital mortality was 2.0%, whereas for stent grafting, the corresponding rates were 0.5% and 0.8%, respectively, indicating better mortality rates for the latter ([**Fig. 2A**](#figure2){ref-type="fig"}). Meanwhile, for replacement surgery in patients with rupture, operative mortality was 19.2%, and inhospital mortality was 22.7%. For stent grafting, the rates were better, at 13.2% and 15.5%, respectively ([**Fig. 2A**](#figure2){ref-type="fig"}). Upon performing statistical tests, the postoperative mortality rate was found to be lower for stent graft placement than for replacement surgery, with p-values of \<0.001 and \<0.0001 for operative mortality and inhospital mortality in patients without rupture, respectively. For operative mortality and inhospital mortality in patients with rupture, the p-values were 0.0586 and \<0.05. However, as patient and anatomical background differed among the candidate patients with ruptured aneurysms, due care should be paid to the fact that comparison of unmatched data between the two groups poses a problem. In patients with rupture, replacement is selected for patients with unstable hemodynamics and anatomic difficulties, whereas stent grafting can be selected for patients with stable hemodynamics and anatomically simple cases.

![Fig. 2 Early clinical results of abdominal aortic aneurysm (AAA). The 30-day mortality and the hospital mortality of non-ruptured AAA ([**Fig. 2A**](#figure2){ref-type="fig"}) and the ruptured AAA ([**Fig. 2B**](#figure2){ref-type="fig"}). Regarding the statistical difference of mortality rates between open repair (replacement) and stent graft, see main text.](avd-11-3-ar.18-00049-figure02){#figure2}

3) Peripheral aneurysms (**Table 1-3**)
---------------------------------------

There were 1,558 registered patients with peripheral aneurysms, with a male-to-female ratio of 1,102 : 456. This ratio indicates that peripheral aneurysms were more common among men. A breakdown of the regions in descending order indicated that the aneurysm affected arteries of the lower limbs in 652 patients, abdominal splanchnic arteries in 502 patients, arteries of the upper limbs in 371 patients, and aortic arch branches in 58 patients, while according to artery, femoral artery aneurysms were most common at 25.4%, followed by "other" ([**Table 1-3**](#table1-3){ref-type="table"}). The large number of aneurysms observed in "other" may have been because this category mainly included internal iliac artery aneurysms. Based on this result, we decided to revise the registration method for internal iliac artery aneurysms. There were 249 patients with rupture (16.0%), which was most commonly observed in the femoral, brachial, and hepatic arteries. This tendency was similar to that prior to 2010. The selection of surgical procedures included ligature, resection, replacement, exclusion, and bypass surgery, with stent grafting selected in 9.1%. The surgical procedure named "other" was inferred to include procedures such as coil embolization.

2. Revascularization for Chronic Arterial Occlusion (**Table 2**)
=================================================================

Chronic arterial occlusion registered in NCD, as shown in [**Table 2**](#table2-1){ref-type="table"}, is divided into five fields including aortic arch branches/upper limbs/abdominal splanchnic arteries, aorta--lower limb arteries, extra-anatomical bypass, thromboendarterectomy of the lower limb arterial system, and endovascular treatment for the lower limb arteries. In this report, we will discuss the results according to different anatomical areas.

###### Table 2 Revascularization for chronic arterial occlusive diseases\*^[@R1])^ Table 2-1 Arterial reconstruction for aortic branches

  Aortic branches                       Cases   Gender   Mortality   Backgrounds   Etiology   Revascularization procedures   Graft materials\*^[@R6])^                                                                                    
  ------------------------------------- ------- -------- ----------- ------------- ---------- ------------------------------ --------------------------- --- --- --- ---- ---- --- ---- --- ----- ---- ---- ---- ---- ---- ---- ---- ---- ---
  Carotid artery                        118     101      17          0             7          4                              106                         0   0   1   11   12   1   92   3   4     3    0    4    1    2    3    1    4    0
  Vertebral artery                      2       1        1           0             0          0                              2                           0   0   0   0    0    0   0    0   1     0    0    0    1    0    0    1    0    0
  Subclavian artery                     113     83       30          0             14         8                              88                          0   0   0   25   0    0   0    0   56    2    3    6    40   8    16   32   1    0
  Multiple lesions of arch branches     15      8        7           0             0          2                              7                           0   0   3   5    0    0   0    0   3     2    8    0    0    2    7    0    3    1
  Upper limb including axillar artery   84      47       37          0             42         21                             59                          1   2   0   22                     31    2    19   0    7    27   6    9    13   2
  Celiac/superior mesenteric artery     69      46       23          1             7          10                             60                          0   1   0   8                      33    10   10   0    1    17   11   3    2    0
  Renal artery                          116     92       24          1             2          5                              99                          0   0   2   15                     104   1    6    0    0    4    2    1    2    0
  Others                                49      37       12          0             19         5                              38                          2   0   0   9    0    0   0    0   29    3    3    2    1    10   4    2    2    2
  Total                                 554     405      149         2             90         53                             451                         3   3   5   92   13   1   92   3   255   21   49   10   51   67   45   49   27   5

###### Table 2-2 Arterial reconstruction for chronic lower limb ischemia

  From aorta to lower limb arterial system              Cases   Gender   Mortality   Backgrounds   Etiology   Graft materials\*^[@R6])^                                                      
  ----------------------------------------------------- ------- -------- ----------- ------------- ---------- --------------------------- ------- ---- ---- --- ---- ------- ------- ------- ----
  Aorto--aorto bypass                                   70      54       16          0             3          2                           62      0    0    3   5    48      18      5       0
  Infrarenal aortic reconstruction (suprarenal clamp)   32      29       3           1             3          0                           32      0    0    0   0    30      3       0       0
  Aorto--femoral bypass\*^[@R7])^                       680     578      102         7             39         51                          661     2    2    0   14   509     195     29      5
  Femoro--popliteal (above knee) bypass                 2,014   1,554    460         12            231        251                         1,998   5    1    1   7    391     1,305   253     21
  Infrapopliteal arterial bypass                        1,616   1,210    406         35            460        394                         1,559   9    8    1   31   135     316     1,129   63
  Femoro--popliteal (below the knee) bypass             658     494      164         12            131        149                         638     3    3    0   8    84      215     341     25
  Femoro--crural/pedal bypass\*^[@R8])^                 984     734      250         23            338        253                         946     7    5    1   23   53      113     810     38
  Others                                                173     132      41          3             25         23                          165     0    0    0   7    61      72      26      4
  Total                                                 4,327   3,351    976         54            733        705                         4,221   15   11   5   63   1,032   1,771   1,360   85

###### Table 2-3 Extra-anatomic bypass\*^[@R9])^

  Extra-anatomical bypass             Cases   Gender   Mortality   Backgrounds   Etiology   Graft materials\*^[@R6])^                                     
  ----------------------------------- ------- -------- ----------- ------------- ---------- --------------------------- ------- --- ---- ----- ----- ---- ----
  Carotid--subclavian bypass          10      6        4           0             1          2                           8       0   2    5     3     2    0
  Axillo--axillary bypass             51      38       13          0             5          2                           39      0   12   17    32    1    1
  Axillo--femoral bypass\*^[@R10])^   397     280      117         10            55         55                          377     0   20   151   239   15   5
  Femoro--femoral cross-over bypass   961     819      142         6             79         114                         934     0   26   269   577   56   6
  Others                              139     103      36          2             18         25                          129     2   8    43    46    20   0
  Total                               1,532   1,223    309         17            155        193                         1,462   2   67   479   877   91   12

\*1) Bypass surgery combined with endovascular treatment is counted in both bypass category ([**Table 2-2**](#table2-2){ref-type="table"}) and endovascular category ([**Table 2-5**](#table2-5){ref-type="table"}). \*2) Including redo operation only. Revision surgery cases should be counted in vascular complication part (see **Table 8**). \*3) Including collagen disease related vasculitis, Behçet disease, fibromuscular dysplasia. \*4) Postoperative irreversible brain complication. \*5) Including percutaneous transluminal angioplasty (PTA), stent, and other endovascular means such as catheter atherectomy. \*6) Only for open surgery. \*7) Including aorto--iliac bypass or ilio--femoral bypasses. \*8) Including popliteal--crural (or pedal) bypass. \*9) Cases underwent extraanatomic bypass because of graft infection should not be included this category. Those cases are listed in vascular complication ([**Table 5**](#table5-1){ref-type="table"}). \*10) A case underwent axillo--femoro--femoral crossover bypass is counted as one case. A case combined with additional contralateral side of axillilo-femoral bypass as second staged surgery is counted as 2 cases. Abbreviations; ASO: arteriosclerosis obriterance, TAO: thromboangiitis obliterans (Buerger's disease), CAS: carotid artery stenting, CEA: carotid endarterectomy, PTA: percutaneous transluminal angioplasty, EVT: endovascular treatment.

######  Table 2-4 Thromboendarterectomy\*^[@R11])^ for chronic lower limb ischemia

  Thromboendarterectomy      Cases   Gender   Mortality   Dialysis cases   Etiology             
  -------------------------- ------- -------- ----------- ---------------- ---------- ----- --- ----
  Aorto--iliac lesion        50      36       14          0                7          49    0   1
  Femoro--popliteal lesion   568     432      136         11               122        553   3   7
  Others                     90      57       33          0                19         85    1   4
  Total                      702     521      181         11               146        682   4   11

###### Table 2-5 Endovascular treatment for chronic lower limb ischemia\*^[@R5])^

  Endovascular treatment                               Cases   Gender   Mortality   Dialysis cases   Etiology                       
  ---------------------------------------------------- ------- -------- ----------- ---------------- ---------- ------- ------- --- ----
  Aorto--iliac lesion\*^[@R12])^                       2,569   2,122    447         12               23         285     2,548   3   17
  Femoro--popliteal lesion\*^[@R12])^                  1,834   1,300    534         7                29         498     1,824   5   4
  Infrapopliteal--ankle lesion\*^[@R12])^              961     651      310         25               48         460     950     1   8
  Others                                               46      30       16          2                1          22      43      2   1
  Total (number of regions underwent EVT)\*^[@R12])^   4,768   3,636    1,132       39               83         1,026   4,727   9   28
  Total (number of limbs underwent EVT)\*^[@R13])^     4,153   3,191    962         32               65         804     4,116   7   26

\*11) Including patch plasty. \*12) When endovascular treatment performed for multiple region, the case should be counted in each region (If a case underwent endovascular treatment in both aorto--iliac and femoro--popliteal region, this case can be counted one in aorto--iliac, and one in femoro--popliteal region). \*13) When a case underwent endovascular treatment in multiple regions, the case is counted as one case. Abbreviations; ASO: arteriosclerosis obriterance, TAO: thromboangiitis obliterans (Buerger's disease), CAS: carotid artery stenting, CEA: carotid endarterectomy, PTA: percutaneous transluminal angioplasty, EVT: endovascular treatment.

1) Aortic arch branches/upper limbs/abdominal splanchnic arteries
-----------------------------------------------------------------

This region includes the carotid artery, vertebral artery, subclavian artery, multiple lesions of the aortic arch branches, axillary artery--brachial artery, celiac artery/superior mesenteric artery, renal artery, and other items. For the carotid artery, revascularization was performed in 118 patients, approximately 80% of whom underwent carotid endarterectomy (CEA) and 10% underwent carotid artery stenting (CAS). In the field of neurosurgery, given that CAS is performed in more than 6,000 cases per year and CEA in more than 3,000 cases per year, the number of patients can be understood based on the historical background, whereby unlike in Europe and the USA, in Japan, surgery for carotid artery stenosis has primarily been performed by the department of neurosurgery. The medical standard for implementing CAS requesting 30 cases experiences of cerebral angiography as the minimum requirement in Japan, which is a kind of barrier for vascular surgeons, is a possible reason for the small number of CAS in this registry.

For the subclavian artery, percutaneous transluminal angioplasty (PTA/stent) with or without stent insertion was performed in half of the patients, followed by axillary--axillary arterial bypass in 35%. For the axillary artery--brachial artery, 50% of the patients were dialysis patients, and PTA/stent was performed in approximately 40%, among which endovascular treatment for vascular access might have been registered in this category by misunderstanding. For the celiac artery/superior mesenteric artery, the underlying disease was arteriosclerosis in 90% of patients; in 50% of patients, PTA/stent was performed, whereas in 30% of patients, other treatment by replacement/bypass was performed. It is inferred that endovascular treatment is the first option in these regions. For the renal artery, revasularization was performed by percutaneous transluminal renal angioplasty in 90% of patients. As devices for renal artery lesions are covered by national health insurance, endovascular treatment had been considered the first-line treatment.

2) Anatomical bypass, extra-anatomical bypass, and endovascular surgery in the field of the aorto--lower limb arteries
----------------------------------------------------------------------------------------------------------------------

In the field of the aortoiliac artery, anatomical surgical revascularization was performed in 782 patients, most of whom had obstructive arteriosclerosis. At present, for bypass surgery in this field, Dacron artificial grafts were commonly used; however, in aortofemoral artery bypass, ePTFE (expanded polytetrafluoroethylene) artificial grafts were used in \>20% of patients, possibly reflecting the inclusion of ilio-femoral artery bypass in this item. Furthermore, there were 34 patients in whom an autogenous vein was used as the vascular graft, and it was inferred that the femoral vein was mainly used in cases with infection. Extra-anatomical bypass includes axillofemoral artery bypass and femoro--femoral crossover bypass, which were performed in 397 patients and 961 patients, respectively. In these procedures, ePTFE vascular grafts have come to be used in \>50% of patients. Overall, surgical bypass was performed in 2,000 patients, while endovascular treatment (primarily for the iliac artery) was performed in 2,569 patients. In recent years, although endovascular treatment is often indicated to be the first-line treatment for lesions in this region, it appears to be used less commonly than shown in reports from Europe and the USA. This discrepancy is likely attributable to the fact that many patients who receive endovascular treatment in other medical departments (cardiology, radiology) are not registered in NCD and that vascular surgeons do not necessarily adhere to endovascular treatment for TASC D lesions, such as long obstructive lesions of the iliac artery, and perform relatively minimally invasive extra-anatomical bypass surgery for the treatment of such TASC D lesions with or without common femoral artery lesions involving the non-stent zone.

In the superficial femoral artery region, above-knee femoro-popliteal artery (FPAK) bypass was performed in 2,014 patients. The bypass conduit used was ePTFE, Dacron, and autogenous vein in 65%, 20%, and 12% of limbs, respectively. Most current guidelines recommend the use of an autogenous vein^[@R4])^; and the results have shown that Dacron is superior to ePTFE when using artificial grafts.^[@R5])^ Therefore, actual circumstances in Japan is different from the guidelines in the USA and Europe. Although the guidelines will possibly change the rate of artificial graft use in Japan, new artificial grafts have become commercially available for which an observation period of several years is probably needed for the selection of the most appropriate material, taking into account the outcomes. Endovascular treatment was performed in 1,894 patients and similar to the aforementioned aortoiliac region, is speculated to be performed less frequently than presumed, based on reports from the USA and Europe. In addition to the fact that many patients who underwent endovascular treatment in other medical departments (medical departments not involved in NCD including cardiology and radiology) were not registered, these results indicate that vascular surgeons were suggested to perform FPAK bypass at the same time as the treatment for common femoral artery lesions involving the non-stent zone and deep femoral artery lesions.

Revascularization below the knee was achieved by femoropopliteal below-knee (FPBK) bypass and distal bypass to infrapopliteal or more distal region in 658 and 984 patients, respectively, whereas patients on dialysis accounted for 20% and 33%, respectively, indicating increasing number of patients including the majority of those with crural arterial lesions reflecting underlying illnesses, such as diabetes and chronic renal failure (maintenance dialysis). An artificial graft was used in 40% and 15% of patients who underwent FPBK and distal bypass, respectively, suggesting that there might be many patients for whom it is considered that an autogenous vein will be inappropriate for bypass conduit due to poor quality or that many institutions have not fully adopted the guideline to thoroughly use an autogenous vein. Endovascular treatment in this area was performed in 961 patients, of which 50% were dialysis patients. It is inferred that endovascular treatment was selected in many dialysis patients because of their poor physical condition which did not suit to bypass surgery.

Thromboendarterectomy was performed in the iliac and femoropopliteal artery regions in only 50 and 568 patients, respectively. This finding suggests that many lesions are well-suited for endovascular treatment in the iliac artery region, whereas the femoropopliteal artery region was speculated to be affected by areas with bends, such as of the common femoral and popliteal arteries, i.e., non-stent zone, and the presence of lesions that are anatomically unsuited for endovascular treatment, such as the deep femoral artery. Other reasons include the fact that thromboendarterectomy is an established procedure in the common femoral arterial region, and its major clinical usefulness is maintained.

We have hereby reported on the current state of revascularization for chronic arterial obstruction in Japan. Our results indicate that endovascular treatment is performed less often in Japan than in the USA and Europe. In terms of investigations of chronic arterial obstruction based on national databases, a report summarizing peripheral vascular disease over 3 years in Germany (2005, 2007, and 2009), reported that the ratio of endovascular treatment-to-bypass surgery was 2 : 1.^[@R6])^ A report based on the national database of Sweden in 2009 found that the choice of treatment for intermittent claudication under the inguinal ligament in the above-knee popliteal artery region is endovascular treatment, with a ratio of 2 : 1 for endovascular treatment-to-surgery.^[@R7])^ Thus, when viewed overall, endovascular treatment appears to be performed more commonly than bypass surgery. In Japan, although the results of a questionnaire survey conducted from 2004 to 2010 cannot be simply compared with those of the present registration, it is clear that an increasing number of vascular surgeons are performing endovascular treatment ([**Fig. 3**](#figure3){ref-type="fig"}), and the incidence of endovascular surgery is expected to increase further in the future.

![Fig. 3 The annual trends of the number arterial reconstructions in aortoiliac, superﬁcial femoral (SFA), and crural/pedal region, comparing open repair and endovascular treatment. The broken line lying between year 2010 and 2011 means the timing of alteration regarding data collection methods. Data has been prospectively registered since January 2011, while the data had been retrospectively collected annually from 2004 until 2010. AK: above the knee, BK: below the knee.](avd-11-3-ar.18-00049-figure03){#figure3}

3. Revascularization for Acute Arterial Occlusion (**Table 3**)
===============================================================

Excluding cases of vascular trauma, 3,799 cases of acute arterial obstruction were registered, and the incidence was approximately 20% and 80% in the upper limb region and lower body region including arteries in abdomen and lower limbs, respectively. Acute arterial obstruction was caused by thrombosis and embolism, which each accounted for approximately half of the cases. This result is consistent with recent reports from the USA.^[@R8])^

###### Table 3 Revascularization for acute arterial occlusive disease                   Non-traumatic acute limb ischemia

  Obstructive artery\*^1)^            Cases   Gender   Mortality   Etiology   Procedure   Graft materials for open surgery                                                                  
  ----------------------------------- ------- -------- ----------- ---------- ----------- ---------------------------------- ------- ----- ------- ----- ---- ----- ----- ----- ----- ----- ----
  Carotid artery                      6       4        2           1          1           0                                  3       3     3       2     0    1     1     1     1     0     0
  Subclavian artery                   75      43       32          4          5           38                                 27      9     26      17    29   3     2     2     10    34    0
  Axillar artery                      51      29       22          5          6           19                                 28      4     38      8     0    6     5     3     4     3     1
  Brachial artery                     567     270      297         18         20          322                                243     2     489     14    2    16    58    7     7     15    3
  Celiac/superior mesenteric artery   82      58       24          16         25          32                                 22      28    34      31    3    6     10    16    6     12    2
  Renal artery                        14      10       4           2          3           6                                  2       6     1       5     1    7     0     2     1     4     0
  Abdominal aorta--iliac artery       644     462      182         83         98          196                                338     108   382     227   18   86    25    13    137   112   5
  Femoro--popliteal artery            2,004   1,265    739         157        213         886                                1,044   69    1,667   246   12   150   91    93    110   145   7
  Crural artery                       616     420      196         60         70          293                                311     12    487     59    7    74    42    38    29    48    5
  Pedal artery                        25      15       10          3          3           11                                 12      2     16      4     0    5     3     3     1     1     1
  Others                              280     193      87          14         20          44                                 176     60    158     94    15   29    19    79    14    16    3
  Total                               3,799   2,394    1,405       292        381         1,615                              1,889   288   2,830   617   81   321   231   228   276   343   24

\*1) The most proximal occluded artery is named in case whose primary occluded artery could not be identified. \*2) Cases with acute worsening occlusion of chronic arterial occlusive disease are excluded. Treatment for those cases are listed in [**Table 2**](#table2-1){ref-type="table"}.

With regard to incidence, in a prospective study conducted in the UK, 93 (10/100,000/year) and 78 cases (8/100,000/year) of acute limb ischemia (ALI) and acute visceral ischemia (AVI), respectively, were reported in a population of 92,728 individuals over a 10-year period.^[@R9])^ The incidence of AVI accounted for 44% of ALI+AVI in the UK, whereas the proportion of AVI per acute arterial obstruction was extremely low in Japan at approximately 2%. This discrepancy is likely attributable to the fact that the British study included patients who did not receive therapeutic intervention, whereas the present data included only patients who underwent revascularization. The 30-day mortality for AVI was 72% in the British report, in contrast to 20% in the present data for revascularization. Therefore, it can be inferred that many AVI patients die without attaining revascularization.

The 30-day mortality rate for ALI in the British prospective study, was 25%; however, the present data showed that the mortality rate for ALI distal to the abdominal aorta was 9.2%. The present data indicate the results for patients who underwent revascularization, which is believed to have led to better outcomes than those reported in the British study.

With respect to the revascularization procedure, approximately 90% of ALI was treated via open surgery. In the future, endovascular treatment is expected to increase (thrombolytic therapy and thrombus aspiration). The conduit used for revascularization at proximal to the popliteal artery was commonly artificial graft. A questionable situation has arisen in which more than half of cases involving crural arteries, for which autogenous vessel graft is recommended, are actually undergoing treatment with artificial grafts.

Furthermore, in the present data, the total number of each region was inconsistent with the total in the lower row of the table, which may have been due to the existence of several cases in which the same patient had obstruction at multiple sites.

4. Treatment for Vascular Trauma (**Table 4**)
==============================================

The site of registered vascular trauma, cause of injury, classification based on the surgical procedure, and type of prosthesis used are presented in [**Table 4**](#table4-1){ref-type="table"}. Overall, 1,030 cases had a combination of arterial and venous trauma. In the NCD database, the cause of vascular trauma was classified into 1) traffic accident, 2) work-related, 3) iatrogenic, and 4) others, among which iatrogenic vascular trauma was the most common, accounting for approximately 64%, followed by traffic accidents (\~11%), and work-related trauma (\~9%). Although graft materials were used in a few cases because most were managed by direct suture and ligature, approximately 40% of graft materials were autogenous vessels. In trauma, as the injured site is often contaminated, autogenous vessel grafting is selected as much as possible in peripheral vascular reconstruction.

###### Table 4 Treatment for vascular trauma Table 4-1 Arterial trauma

  Injured artery                                 Cases   Gender   Mortality   Cause of trauma   Procedure   Graft materials                                                                        
  ---------------------------------------------- ------- -------- ----------- ----------------- ----------- ----------------- ---- ----- ----- ----- ---- ---- ---- ---- ----- ---- ---- ---- ---- ---
  Carotid artery                                 11      8        3           1                 2           2                 2    4     3     5     1    0    1    2    3     0    1    1    0    0
  Subclavian artery                              12      8        4           1                 2           1                 1    8     2     7     0    0    1    1    2     1    0    1    0    0
  Axillar artery                                 12      6        6           0                 0           3                 4    4     1     3     0    2    4    1    2     0    4    0    2    0
  Brachial artery                                181     116      65          2                 4           3                 14   150   14    133   1    7    9    0    20    14   13   0    4    0
  Descending aorta (thoracic/thoracoabdominal)   37      23       14          14                14          15                4    6     12    3     0    10   0    12   2     10   0    8    2    0
  Celiac/superior mesenteric artery              17      17       0           2                 3           6                 1    7     3     2     0    0    0    6    6     4    0    0    0    0
  Renal artery                                   4       4        0           2                 2           1                 2    1     0     0     0    1    0    1    1     1    0    1    0    0
  Abdominal aorta--iliac artery                  94      48       46          12                15          13                5    60    15    34    3    5    17   20   14    7    1    13   8    2
  Femoro--popliteal artery                       398     258      140         55                76          27                28   300   42    293   14   19   34   7    18    18   42   8    15   0
  Crural artery                                  27      20       7           0                 0           5                 8    9     5     7     0    3    10   0    2     6    11   1    0    0
  Others                                         166     111      55          35                37          35                15   62    54    60    3    3    5    11   63    25   5    2    1    1
  Total                                          949     610      339         123               154         105               83   609   150   547   22   48   78   60   131   84   75   34   30   3

###### Table 4-2 Venous trauma\*^1)^

  Injured vein                       Cases   Cause of trauma   Procedure   Graft materials                                                   
  ---------------------------------- ------- ----------------- ----------- ----------------- ---- ---- --- --- --- --- ---- ---- --- --- --- ---
  Superior vena cava                 1       1                 0           0                 0    0    0   0   0   0   1    0    0   0   0   0
  Inferior vena cava                 8       1                 2           2                 3    4    0   0   0   0   1    3    0   0   0   0
  Brachiocephalic--subclavian vein   6       0                 1           3                 2    3    0   1   0   0   1    2    0   0   1   0
  Iliac--femoral--popliteal vein     39      3                 3           32                1    34   1   0   1   1   3    3    0   1   1   0
  Others                             27      4                 3           11                9    8    1   2   2   0   13   3    4   0   0   1
  Total                              81      9                 9           48                15   49   2   3   3   1   19   11   4   1   2   1

\*1) Cases with vessel injury involving both vein and accompanying artery are listed in [**Table 4-1**](#table4-1){ref-type="table"}.

1) Iatrogenic vascular trauma
-----------------------------

The underlying mechanism of iatrogenic vascular trauma is speculated to include catheter-related trauma and accidental vascular injury during surgery. Catheter-related trauma includes hematoma arising at the vascular puncture site, false aneurysm, arteriovenous fistula, dissection, obstructive thrombus, infection, and abscess, i.e., access site complications, as well as puncture, hemorrhage, dissection, obstruction, and migration of foreign body such as guidewire and catheter tip. The type of catheters causing the abovementioned trauma include those used for angiography and endovascular treatment, as well as those used in visceral artery embolization for malignant tumor, arterial injection chemotherapy, and transvenous catheter feeding.^[@R10],[@R11])^ Upon examining different sites of iatrogenic vascular trauma in the present study, the arteries of the lower limbs were most commonly affected (47%), followed by the upper limb arteries (25%), most of which were speculated to be complications of the catheter puncture site. Based on a factual survey conducted by the National Cerebral and Cardiovascular Center in Japan in 2012, the number of cardiac catheterizations exceeded 500,000 cases.^[@R12])^ Furthermore, the incidence of complications of the catheter puncture site is generally reported to be 2.1%--6.6%.^[@R13])^ Among which, only those requiring surgical repair were speculated to be registered in NCD; however, there were few registrations, and thus, we cannot conclude that these data reflect the actual state. Intraoperative accidental vascular injury was also included in iatrogenic vascular trauma, in which injury can occur in the carotid artery during head and neck surgery, in the thoracic aorta and associated branches during respiratory and esophageal surgeries, in the abdominal aorta, iliac vessels, and visceral blood vessels during gastrointestinal surgery, and in the vessels of the upper and lower limbs during orthopedic surgery. As these are included under the category of iatrogenic in NCD, the injury mechanisms noted above are unclear.

2) Traffic accidents
--------------------

Examination of vascular trauma caused by traffic accidents based on different sites revealed that the arteries of the lower limbs were most commonly affected, accounting for approximately 27% of cases. In trauma caused by accidents, such as the collision of a car with a pedestrian, or accidents that occur while driving a motorcycle, blunt force trauma can occur in the blood vessels near the body surface of the four limbs where direct force is easily applied. Furthermore, bone fracture and bone fragments can cause penetrating trauma to nearby blood vessels. The second most common site of trauma was the descending and thoracoabdominal aortas (12%), followed by the abdominal aorta and iliac artery (11%). In car collisions, wearing a seatbelt and improved safety and technology of the vehicle have resulted in less direct force being applied to the major blood vessels. However, in high-speed collisions, the sudden decrease in speed causes mediastinal movement, and the stress is concentrated on the branches of the cervical region and arm and associated ramifications attached to the thorax, in particular dissection and laceration/transection of the thoracic descending aorta occurs in the left subclavian artery branching site. Compared with other causes described below, the high rate of injury to the thoracic aorta is attributed to the characteristics of traffic injury. The steering wheel, dashboard, and seatbelt can also cause blunt force trauma to the large vessels of the abdomen.

3) Work-related trauma
----------------------

When strong force is sustained by falling from hight or from a heavy falling object, it can cause blunt force trauma to the major blood vessels. Furthermore, sharp objects, such as glass fragments, can fly in all directions from an explosion, and sharp penetrative vascular trauma and vascular compression trauma can occur in the event of being caught in a machine. These injury mechanisms are speculated to be common to occupations associated with risk, such as workers in construction sites, and trauma classified as "work-related" in this database is assumed to be such accidents during occupation work. The database registered 92 cases, and the arteries that are close to the body surface of the four limbs where direct force is easily applied accounted for 60%.

4) Other vascular trauma
------------------------

Excluding iatrogenic and traffic accident-related traumas, other injury mechanisms for vascular trauma include accidents, deliberate harm, and acts of self-harm. Furthermore, damage to blood vessel walls caused by illness, such as vascular invasion of a tumor, can be considered another type of vascular trauma. ① Accidents: Natural disasters, sports injury, and falls other than at work can cause injury. ② Deliberate harmful acts/acts of self-harm: Harmful acts using a blunt or sharp instrument. In the event of blood vessels, sharp injuries are often speculated to be acquired with a cutting instrument. Although rare in Japan, gunshot wounds are included here. ③ Damage to the blood vessel wall by other illnesses, such as tumor invasion: When direct tumor invasion and abscesses causes vascular wall destruction and when false aneurysm and thrombi form, surgical treatment of the affected blood vessel is required. These injuries are not caused by medical treatment and are thus not classified as iatrogenic but currently classified as "vascular trauma from other causes."

As noted above, we analyzed vascular trauma; however, generally, few cases were registered, and the actual state may not be reflected by these data. In departments of radiology, many patients are treated with embolization, and in departments of orthopedics, a considerable number of patients undergo amputation when vascular repair is deemed difficult; moreover, some vascular traumas in the departments of general surgery and trauma surgery are treated by ligation and suture hemostasis and might not be registered as vascular surgery. Therefore, we believe that information should be shared with emergency medical care services.

5. Surgery for Vascular Complications after Revascularization (**Table 5**)
===========================================================================

There were 1,615 surgical cases of revascularization-related complications, including artificial graft infection in 445 patients, anastomotic aneurysm in 240 patients, autogenous graft aneurysm in 86 patients, artificial graft degradation in 33 patients, and repair for restenosis and acute obstruction of the prostheses in 811 patients. The incidence of complications is of great interest; however, we were unable to calculate the incidence because the total number of surgeries conducted to date could not be ascertained.

###### Table 5 Revascularization for vascular complication after revascularization Table 5-1 Graft infection

  Position of infected graft        Cases   Mortality   Procedure for graft infection   Material for revision or redo surgery                                  
  --------------------------------- ------- ----------- ------------------------------- --------------------------------------- ---- ----- ---- ----- ---- --- ----
  Thoracic descending aorta         2       0           1                               0                                       0    2     1    0     0    0   0
  Thoracoabdominal aorta            9       1           2                               3                                       0    6     3    0     0    0   1
  Abdominal aorta--iliac artery     46      7           12                              14                                      22   10    20   16    3    0   1
  Abdominal aorta--femoral artery   31      1           3                               7                                       7    17    4    7     6    0   0
  Femoro--popliteal artery          123     7           22                              18                                      17   88    13   40    17   1   1
  Others\*^1)^                      234     12          36                              24                                      32   177   31   75    15   0   11
  Total                             445     28          76                              66                                      78   300   72   138   41   1   14

\*1) Cases with graft infection involving aortic arch branch or upper limb artery are listed on this column.

###### Table 5-2 Anastomotic aneurysm\*^2)^

  Location of anastomotic aneurysm             Cases   Mortality   Cause of aneurysm treated at the primary operation   Repair procedure   Material for repair surgery                                                
  -------------------------------------------- ------- ----------- ---------------------------------------------------- ------------------ ----------------------------- ---- ---- ---- --- ---- ----- ---- ---- ---- ----
  Aortic arch branch                           6       1           4                                                    0                  0                             1    1    1    0   1    5     3    1    0    1
  Upper limb artery including axillar artery   44      1           4                                                    0                  0                             13   27   1    2   0    40    0    5    5    1
  Thoracic aorta                               28      2           9                                                    0                  0                             0    19   0    0   24   6     8    4    0    16
  Splanchnic artery                            4       1           1                                                    0                  0                             1    2    0    1   1    3     3    0    0    0
  Renal artery                                 0       0           0                                                    0                  0                             0    0    0    0   0    0     0    0    0    0
  Abdominal aorta                              69      1           42                                                   1                  0                             3    23   6    1   30   34    23   9    0    16
  Iliac artery                                 34      5           12                                                   0                  0                             4    18   2    0   20   14    4    5    1    13
  Femoral artery                               56      1           27                                                   0                  2                             7    20   15   3   0    38    16   12   8    1
  Popliteal or more distal lower limb artery   17      1           11                                                   0                  1                             1    4    5    3   1    8     3    3    5    0
  Total                                        240     13          109                                                  1                  3                             30   97   30   9   66   142   58   39   19   32

\*2) Cases with infectious pseudoaneurysms located at the anastomotic site to the artificial graft are listed in [**Table 5-1**](#table5-1){ref-type="table"}. \*3) Including the atherosclerotic aneurysm. \*4) Including TAO, collagen disease, Behçet disease, and fibromuscular dysplasia.

######  Table 5-3 Autogenous graft aneurysm

  Revascularization area   Cases   Mortality   Repair procedure        
  ------------------------ ------- ----------- ------------------ ---- ----
  Visceral artery          1       0           0                  1    0
  Upper limb artery        44      0           7                  10   29
  Lower limb artery        28      1           6                  3    19
  Others                   13      1           1                  3    9
  Total                    86      2           14                 17   57

###### Table 5-4 Graft degeneration

  Revascularization area            Cases   Mortality   Initial revascularization procedure   Degenerated material   Repair procedure   Material for repair surgery                                                 
  --------------------------------- ------- ----------- ------------------------------------- ---------------------- ------------------ ----------------------------- ---- ---- --- ---- --- --- --- ---- ---- ---- ---
  Descending thoracic aorta         0       0           0                                     0                      0                  0                             0    0    0   0    0   0   0   0    0    0    0
  Thoracoabdominal aorta            1       0           1                                     0                      0                  0                             0    0    1   1    0   0   0   0    1    0    0
  Abdominal aorta--femoral artery   6       0           2                                     3                      1                  0                             4    1    1   4    0   1   0   1    2    3    0
  Femoro--popliteal artery          5       0           2                                     3                      0                  0                             3    2    0   2    1   0   0   2    3    0    1
  Others                            23      0           5                                     6                      0                  11                            8    13   1   7    5   0   0   11   5    10   1
  Total                             33      0           9                                     11                     1                  11                            14   16   2   13   6   1   0   13   10   13   2

###### Table 5-5 Repair operation for graft stenosis or acute thrombosis\*^5)^

  Initial procedure                                 Cases   Mortality   Repair procedure   Material for repair surgery                                       
  ------------------------------------------------- ------- ----------- ------------------ ----------------------------- ----- ----- ----- ----- ----- ----- ----
  Reconstruction of aorta or its primary branches   117     5           29                 10                            35    43    16    45    32    4     4
  Revascularization of upper limb                   219     8           76                 25                            38    65    41    18    71    39    13
  Revascularization of lower limb                   486     15          224                31                            141   108   50    61    129   135   10
  Total                                             811     26          319                65                            210   214   106   122   227   178   27

\*5) Including stenosis such as the anastomotic stenosis, graft stenosis or occlusion, and restenosis at the site of endarterectomy.

1) Artificial graft infection
-----------------------------

Based on different regions, artificial graft infection affected the descending thoracic aorta--abdominal aorta region in 11 patients, the abdominal aorta--iliac/femoral artery region in 77 patients, and the femoral--peripheral artery region in 123 patients. In the aorta--iliac/femoral artery region, repair of infection was performed with orthotopic replacement and extra-anatomical bypass (EAB) in 21 and 29 patients, respectively, with EAB being performed more commonly. In contrast, at sites peripheral to the femoral artery, the number of patients who underwent orthotopic replacement and EAB were comparable; however, "other" surgical procedures were the most common in this region. The underlying reason could be the treatment of many patients by infected graft removal alone, suggesting poor prognosis for the limbs. The graft material used for infection was ePTFE, polyester, and autogenous vessel in 138, 72, and 41 patients, respectively. The operative and inhospital mortality rates were 6.3% and 17.1%, respectively, indicating poor prognosis. With regard to underlying factors of artificial graft infection, although not examined in the present study, Siracuse et al. reported that the incidence of artificial graft infection of the femoral artery was 3.8%, and risk factors included repeat surgery, the presence of active infection at the time of the initial surgery, diabetes, and female sex.^[@R14])^

2) Anastomotic aneurysms
------------------------

The most common underlying pathological cause of anastomotic aneurysm was arteriosclerosis in 109 patients, followed by infection in 30 patients. Based on the database, the abdominal aorta followed by the femoral artery were most often affected. Although anastomotic aneurysms were common in the arteries of the arms, affecting 44 patients, many of these anastomotic aneurysms were highly likely included from vascular access for dialysis. For the repair procedure, repair by stent grafting was often performed for anastomotic aneurysms central to the iliac artery, whereas replacement or exclusion and bypass surgery were often performed for anastomotic aneurysms peripheral to the femoral artery. Thirteen mortalities were noted (5.4%), among which the iliac artery was affected in five patients.

3) Autogenous graft aneurysm
----------------------------

Among the 86 patients who underwent autogenous vessel grafting, aneurysm most commonly affected the arteries of the upper limbs in 44 patients, which was attributed to the relationship with vascular access. For this reason, the surgical procedure was more often possibly considered "other" than "exclusion or bypass," and simple ligation or aneurysm resection with end-to-end anastomosis was performed for vascular access related aneurysms. Vascular access related aneurysms, including aneurysms at the site of vascular access anastomosis, should be registered as vascular access repair by nature. Therefore, with respect to the type of vascular surgery, upon selecting "other vascular diseases and related surgery" rather than "surgery for revascularization-related complications" and when selecting "vascular access surgery for dialysis" in that division, an option appears for "vascular shunt aneurysm repair." In the future, awareness of these registration methods needs to be raised.

4) Artificial graft deterioration
---------------------------------

Surgery was needed in 33 patients including polyester grafts in 14 patients and ePTFE in 16 patients due to deterioration of their artificial grafts. As the total number of implanted artificial grafts for each material are unknown, we were unable to determine the difference in the deterioration rate between different types of artificial grafts.

5) Surgical repair of restenosis and acute obstruction of prostheses
--------------------------------------------------------------------

Surgical repair of prostheses was most commonly performed for the arteries of the lower limbs in 486 patients, and the surgical procedure in descending order was patch/thrombectomy, bypass surgery, and endovascular treatment. By contrast, endovascular treatment most commonly performed surgical repair of the prostheses of the aorta and its primary branches. Surgical repair of prostheses using the arteries of the upper limbs was performed in 219 cases; however, as expected, it is inferred that a considerable number of cases of vascular access surgery were intermixed. As per number 4) above, we would prefer that stenosis and obstruction of vascular access to be registered as "other vascular disease and related surgery" rather than "surgery for vascular complications after revascularization."

6. Venous Surgery (**Table 6**)
===============================

1) Varicose veins
-----------------

Surgery for varicose veins was performed in 18,864 patients, with a male-to-female ratio of approximately 1 : 2. Compared with 2010, the number of surgeries increased by approximately 70%; however, the advent of new surgical procedures, such as venous ablation, as mentioned below, appeared to have influenced this increase in addition to the change in tabulation method. Surgeries for varicose veins accounted for most of venous surgeries at 97%. The procedure was most commonly performed by vein stripping (±sclerotherapy) in 12,164 patients (64%). In January 2011, endovenous laser ablation (EVLA) was approved in Japan for varicose veins and subsequently came into practice. In the 2011 tabulation, EVLA was speculated to be registered as "other"; however, 3,282 cases (17%) were registered as "other" surgery. Based on a survey conducted by the Japan Society of Phlebology in 2013, EVLA was the surgical procedure most commonly performed among surgeries for varicose veins.^[@R15])^ In the guideline by the American Venous Forum, the application of endovenous ablation is recommended for the saphenous vein,^[@R16])^ and the incidence of EVLA was expected to increase in the future in Japan.

###### Table 6 Venous surgery Table 6-1 Varicose veins

  Varicose veins treatment      Cases\*^1)^   Male    Female   30-day mortality
  ----------------------------- ------------- ------- -------- ------------------
  High ligation±sclerotherapy   3,418         1,102   2,316    0
  Stripping±sclerotherapy       12,164        4,742   7,422    1
  Others                        3,282         1,012   2,270    0
  Total                         18,864        6,856   12,008   1

\*1) Only one procedure can be registered in one leg.

###### Table 6-2 Deep vein thrombosis (DVT)

  DVT treatment                          Cases   Male   Female   30-day mortality
  -------------------------------------- ------- ------ -------- ------------------
  Thrombectomy                           68      35     33       2
  Catheter-directed thrombolysis\*^2)^   40      23     17       0
  Bypass                                 6       4      2        0
  IVC filter insertion\*^3)^             287     119    168      4
  Total                                  348     153    195      6

\*2) Including the catheter-directed thrombolysis using hydrodynamic thrombectomy catheter. \*3) Including temporary IVC filter.Abbreviations; IVC: inferior vena cava.

###### Table 6-3 Upper limb vein obstruction

  Treatment of vein obstruction    Cases   Male   Female   30-day mortality
  -------------------------------- ------- ------ -------- ------------------
  Thrombectomy                     51      22     29       1
  Catheter-directed thrombolysis   8       4      4        0
  Bypass                           32      18     14       2
  SVC filter insertion             1       0      1        0
  Total                            88      44     44       2

######  Table 6-4 Vena cava reconstruction

  Vena cava reconstruction   Cases   Mortality   Etiology   Treatment procedures   Material for open surgery                                           
  -------------------------- ------- ----------- ---------- ---------------------- --------------------------- --- --- --- ---- ---- ---- --- --- ---- ---
  SVC reconstruction         22      0           3          13                     5                           4   1   5   4    9    3    1   1   7    5
  IVC reconstruction         45      2           2          39                     1                           5   5   0   14   1    24   6   2   8    3
  Total                      67      2           5          52                     6                           9   6   5   18   10   27   7   3   15   8

Abbreviations; IVC: inferior vena cava, SVC: superior vena cava.

###### Table 6-5 Budd--Chiari syndrome

  Treatment       Cases   Gender   Mortality   Material for open surgery                   
  --------------- ------- -------- ----------- --------------------------- --- --- --- --- ---
  Shunting        4       2        2           0                           1   0   2   0   0
  Decompression   0       0        0           0                           0   0   0   0   0
  Total           4       2        2           0                           1   0   2   0   0

2) Deep vein thrombosis
-----------------------

Treatment of thrombosis included thrombectomy, catheter-directed thrombolysis (CDT), and bypass surgery in 68 (20%), 40 (11%), and 6 patients (2%), respectively. Although a decrease of \>40% was observed in comparison with the 2010 results, inferior vena cava filter (VCF) insertion was most commonly performed with 287 patients (82%). In December 2012, the Ministry of Health, Labour and Welfare issued a notice recommending the implementation of regular observations for permanent VCF and their removal; however, this was considered as one factor underlying the decrease in VCF. Furthermore, the inconsistency between the overall number of surgeries and the sum of the number of specific items is attributed to the existence of overlapping of patients who underwent multiple surgeries.

3) Venous obstruction of the arms
---------------------------------

Surgery was reported to be performed in 88 cases. The procedures included thrombectomy, bypass surgery, and CDT in 51 (58%), 32 (36%), and 8 patients (9%), respectively. There were four overlapping cases.

4) Vena cava reconstruction
---------------------------

Overall, 67 cases of vena cava reconstruction were reported, and based on the database, the reconstruction ratio for the superior vena cava system to the inferior vena cava system was 1 : 2. Tumor was the most common causative pathology (52 patients, 78%). There were two (3.0%) and five cases (7.5%) of operative and inhospital mortalities, respectively, in which treatment was aggressively performed. The surgical procedure most commonly performed was replacement, with 18 patients, and PTA±stenting was often performed in the superior vena cava system, with 9 patients (the registration of the surgical procedure was possibly omitted in 1 patient). The registration included 33 prostheses used, of which ePTFE was the most commonly used, with 15 patients.

5) Budd--Chiari syndrome
------------------------

In total, four patients had Budd--Chiari syndrome, indicating that surgery was rare. All procedures were performed by shunting. Only two cases were registered, and both used ePTFE as the prosthesis.

7. Other Vascular Diseases and Related Surgeries (**Table 7**)
==============================================================

1) Popliteal artery entrapment syndrome and cystic adventitial disease
----------------------------------------------------------------------

Only a few cases were registered, and thus, these can be considered rare diseases; however, they are important diseases that require differentiation from other chronic arterial occlusions, such as arteriosclerosis obliterans, as specified in the guidelines for the management of peripheral occlusive disease of the Japan Circulation Society. The few registered cases might be attributable to the fact that treatment is administered without adequate differentiation from other chronic arterial occlusions. However, compared with 2006 (note that the tabulation method differs), 8 and 20 cases in 2006, and 13 and 49 cases in 2011 were registered for popliteal artery entrapment syndrome and cystic adventitial disease, respectively, indicating a large increase in both conditions and suggesting that the rate of diagnosis has improved.

###### Table 7 Other vascular diseases Table 7-1 Popliteal artery entrapment syndrome

  Treatment           Cases   30-day mortality
  ------------------- ------- ------------------
  Myotomy             5       0
  Revascularization   18      0
  Total               20      0

###### Table 7-2 Adventitial cystic disease

  Treatment                     Cases   30-day mortality
  ----------------------------- ------- ------------------
  Cyst excision±patch plastry   36      1
  Replacement                   12      0
  Bypass                        4       0
  Total                         49      1

###### Table 7-3 Thoracic outlet syndrome (TOS)

  Treatment                    Cases   Male   Female   30-day mortality   Type of TOS\*^1)^       
  ---------------------------- ------- ------ -------- ------------------ ------------------- --- ---
  Rib resection\*^2)^          1       1      0        0                  1                   0   0
  Rib resection+scalenectomy   7       3      4        0                  6                   0   2
  Bypass                       5       4      1        0                  1                   0   4
  Total                        12      7      5        0                  8                   0   5

\*1) In the case with mixture type, the type having the most significant impact on the clinical symptom is listed. But, if the impacts are similar, multiple response is allowed. \*2) Including cervical rib.

###### Table 7-4 Vascular access operation

  Treatment                                                    Cases    30-day mortality
  ------------------------------------------------------------ -------- ------------------
  Arteriovenous access creation by autogenous material         8,940    100
  Arteriovenous access creation by artificial material\*^3)^   2,114    38
  Open surgery for access repair                               1,840    34
  Endovascular access repair                                   3,075    22
  Arterial transposition                                       327      12
  Total                                                        16,296   206

\*3) Including cases with access repair using artificial graft.

###### Table 7-5 Surgery for lymphedema

  Treatment                  Cases   Male   Female   30-day mortality
  -------------------------- ------- ------ -------- ------------------
  Lymphovenous anastomosis   24      2      22       0
  Lymph drainage operation   1       0      1        0
  Resection                  24      14     10       0
  Total                      49      16     33       0

###### Table 7-6 Sympathectomy

  Sympathectomy            Cases   30-day mortality
  ------------------------ ------- ------------------
  Thoracic sympathectomy   20      0
  Lumbar sympathectomy     15      0
  Total                    35      0

###### Table 7-7 Amputation of upper limb

  Amputation level    Cases   30-day mortality
  ------------------- ------- ------------------
  Digit               12      1
  Forearm/upper arm   0       0
  Total               12      1

######  Table 7-8 Amputation of lower limb\*^4)^

  Amputation level          Cases   30-day mortality   Etiology              
  ------------------------- ------- ------------------ ---------- ----- ---- ----
  Toe                       387     11                 156        201   7    23
  Transmetatarsal           123     2                  42         73    0    8
  Lisfranc/Chopart          40      2                  10         27    0    3
  Syme                      6       0                  1          5     0    0
  Below-Knee                202     18                 63         125   3    10
  Through-Knee/Above-Knee   273     28                 159        84    3    27
  Hip                       6       0                  1          5     0    0
  Total                     1,037   63                 436        516   13   71

\*4) Except the amputation not due to ischemia. Abbreviations; ASO: arteriosclerosis obriterance, DM-ASO: diabetic ASO, TAO: thromboangiitis obliterans (Buerger's disease).

2) Thoracic outlet syndrome
---------------------------

Twelve cases of thoracic outlet syndrome were registered in NCD, which was a very small number. Among the registrations, bypass surgery was performed in five patients, and the remaining seven patients underwent scalenectomy or costectomy. As many surgical procedures other than bypass surgery are performed by departments of orthopedic surgery, the actual number of cases may not be fully reflected.

3) Vascular access surgery
--------------------------

This surgical procedure was performed even by the departments of urology and nephrology, with up to 16,296 cases registered in NCD, accounting for 24% of vascular surgeries. As noted above, "surgery for vascular complications after revascularization" is speculated to include surgical repair of vascular access, and more vascular access surgeries were speculated to be actually performed. In creating vascular access, the ratio of autogenous vessels to artificial vessels was 8,940 : 2,114, and methods of repair for access trouble included open repair and endovascular treatment in 1,840 and 3,075 cases, respectively.

4) Lymphedema surgery
---------------------

Conservative treatment is indicated for most cases of lymphedema; therefore, only a few cases were registered in departments of surgery. In contrast, treatment using this procedure has recently increased in departments of plastic surgery, and it is inferred that surgery of the lymphatic vessels is often performed apart from vascular surgery.

5) Sympathectomy
----------------

Registrations for sympathectomy were few, suggesting that the number of candidate patients for this procedure is declining. The breakdown included thoracic and abdominal surgeries in 20 and 15 patients, respectively. The reduction in the number of cases has been speculated to be influenced by the fact that there are fewer patients with Buerger's disease and because highly advanced medical treatment comprising therapeutic angiogenesis is being performed for patients for whom sympathectomy was conventionally indicated.

6) Amputation of the upper and lower limbs
------------------------------------------

Upper and lower limb amputations were performed in 12 and 1,037 patients. As upper limb amputation was often performed by departments of orthopedic surgery, the actual number of cases is not reflected. With regard to lower limb amputations, such amputations are performed by plastic surgeons and orthopedic surgeons in an increasing number of facilities as part of team-based medical care; and thus, we believe that the actual number throughout Japan is not reflected. It should be noted that incidence of above-knee amputations was higher than that of below-knee amputations, as was the associated operative mortality ([**Fig. 4**](#figure4){ref-type="fig"}). For foot amputation, below-knee amputations, and above-knee amputations, the operative mortalities were 2.7%, 8.9%, and 10.3%, respectively (p\<0.001). That is, for major amputations, the operative mortality was significantly higher, and the results showed an even higher operative mortality rate when amputations were performed higher than above the knee.

![Fig. 4 The number of lower limb amputations and their mortality rates in each amputation level. The value on the top of each bar indicates the 30-day mortality rate. The mortality rate after amputation surgery became signiﬁcantly higher in according to higher amputation level (p\<0.001). BK: below the knee, AK: above the knee.](avd-11-3-ar.18-00049-figure04){#figure4}

Conclusion
==========

Surveys of vascular surgery have been conducted continuously, and with the appearance of a new tool, i.e., NCD, the survey in the field of vascular surgery made great strides. The determination of vascular surgery items registered in NCD, as a rule, followed the items in the questionnaire survey items, which is an important asset. The number of registering institutions has increased, and while due care is required when interpreting changes in the number of surgical procedures, the fact that the details of vascular surgery throughout Japan have been clarified marks significant progress in ascertaining the state of vascular surgery in Japan. However, many issues remain. The first major purpose of participation in NCD is to apply the NCD data to improve the quality of medical care. Fortunately, vascular surgery has a low operative mortality rate, and thus the quality of most procedures cannot be evaluated by the mortality rate in the short-term, i.e., one month postoperatively. These vascular surgeries aim to improve the quality of life of patients and to this end, studies should be conducted to identify an evaluation index for surgical quality and how the results of such evaluations could lead to better surgical outcomes. By contrast, the operative mortality rate, such as that for surgery of the major blood vessels, can serve as an indicator of quality; therefore, a method of providing feedback for treatment outcomes in actual practice should be examined. Although already in practice in the field of cardiac surgery, we anticipate the implementation of a function capable of comparing the outcomes of an individual institution after risk adjustment with the outcomes throughout Japan in real time. Proceeding with clinical research using NCD is a means of improving the quality of medical care. Clinical research is planned in the future based on the clinical research promotion committee of JSVS. Furthermore, to improve the reliability of the database, we hope that efforts will be made to verify the quality of the data by site visits. Working to address these issues will enable further progress. With the future remarkable cooperation of all members, we hope to further develop the vascular surgery database in NCD. We hope that the NCD data will be useful to all members of this society.
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